spacer
home > ict > spring 2020 > the future awaits us
PUBLICATIONS
International Clinical Trials

The Future Awaits Us






EPC: In Medical Writing – A Bold New Path: The Future Awaits Us, Lisa A Cloutier at Janssen Research & Development discusses outsourcing trends in medical writing. What do you think the future will hold for medical writing services?

Barry Drees: I have been in medical writing for over 30 years, and it seems that every five years or so, the outsourcing trend pendulum swings back and forth between ‘everything should be done in-house’ and ‘virtual company: outsource everything’. I believe that the ideal solution is somewhere in the middle, where a company maintains a core of medical writing experience but uses outside contractors in times of peak demand (such as large submissions) or for specialist expertise. So, I see a very secure future for contract medical writers.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author

Barry Drees received his PhD in Molecular Genetics at the University of California, US. Following his postdoctoral work as a fellow of the National Institute of Health, he worked as a Medical Writer at Hoechst/Aventis for 12 years. Barry is a frequent speaker on medical writing, statistics, and other scientific communication topics for a number of associations and companies in the pharma industry. He is a past President of the European Medical Writers Association (EMWA) and is a former Editorin- Chief of the EMWA journal. He is currently a Co-Founder and Senior Partner of Trilogy Writing & Consulting, continuing to personally lead submission teams and provide training for the industry around the world.
Print this page
Send to a friend
Privacy statement
News and Press Releases

X-Chem Acquires ComInnex

WALTHAM, Mass.; Oct. 25, 2021 (Business Wire) – X-Chem, the pioneer of DNA-encoded library (DEL) technology and recognized leader in generating actionable results to drive small molecule drug discovery, today announced the acquisition of ComInnex, a leading European provider of synthetic chemistry services and novel chemical technologies to support early-stage drug discovery.
More info >>

White Papers

Systems Engineering for Complex Portable Medical Device Development

Phillips-Medisize

As the demand for complex, portable medical devices continues to grow, reducing risk and increasing efficiency during the development of these products should be paramount. Taking a systems-engineering (SE) approach to development provides a holistic, organized, and deliberate method for identifying as well as reducing both patient and business risks early in the process. Furthermore, it facilitates efficient progression throughout the entire product development life cycle.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement